AI Analysis

Log in to generate an AI summary for this stock.

Log in to generate a MOAT report for this stock.

Log in to generate an earnings report for this stock.

Log in to generate an operating leverage report for this stock.

Log in to generate a management report for this stock.

Log in to generate a valuation report for this stock.

Axcelis Technologies, Inc.

$113.43 +$27.31 (+31.71%)
NASDAQ · 11 Sep 2026 20:00 UTC
Previous Close
$113.3
Day Range
$113.2$117.36
Year Range
$73.6$193.78
Market Cap
3.49B
AVG Volume
530.87K
Trailing/Forward PE
37.81/21.53
PEG ratio
1.34
Dividend Yield
-
Next Earnings Date
2026-11-03
Primary Exchange
NASDAQUS
Revenue (USD) · TTM
0500M1B1.5B24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
ACLS Revenue (USD) · TTM by quarter
PeriodRevenue (USD) · TTM
26 Q2866.07M
26 Q1845.44M
25 Q4839.05M
25 Q3853.13M
25 Q2896.09M
25 Q1958.06M
24 Q41.02B
24 Q31.08B
24 Q21.11B
24 Q11.13B
Net Income (USD) · TTM
0100M200M300M24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
ACLS Net Income (USD) · TTM by quarter
PeriodNet Income (USD) · TTM
26 Q292.79M
26 Q1100.87M
25 Q4120.24M
25 Q3135.9M
25 Q2158.49M
25 Q1177.98M
24 Q4200.99M
24 Q3222.09M
24 Q2239.45M
24 Q1250.16M
Operating Income (USD) · TTM
0100M200M300M24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
ACLS Operating Income (USD) · TTM by quarter
PeriodOperating Income (USD) · TTM
26 Q289.42M
26 Q198.11M
25 Q4119.32M
25 Q3137.68M
25 Q2159.57M
25 Q1183.41M
24 Q4210.79M
24 Q3235.31M
24 Q2260.08M
24 Q1270.98M
EBITDA (USD) · TTM
0100M200M300M400M24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
ACLS EBITDA (USD) · TTM by quarter
PeriodEBITDA (USD) · TTM
26 Q2127.7M
26 Q1137.51M
25 Q4159.92M
25 Q3178.46M
25 Q2204.59M
25 Q1226.19M
24 Q4251.54M
24 Q3279.5M
24 Q2297.12M
24 Q1303.78M
Cash Flows (USD) · TTM
050M100M150M200M24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
ACLS Cash Flows (USD) · TTM by quarter
PeriodCash Flows (USD) · TTM
26 Q265.55M
26 Q188.47M
25 Q4107.01M
25 Q3124.03M
25 Q2122.55M
25 Q1122.87M
24 Q4128.64M
24 Q3175.94M
24 Q2152.81M
24 Q1144.5M
EPS (USD) · TTM
0246824 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
ACLS EPS (USD) · TTM by quarter
PeriodEPS (USD) · TTM
26 Q22.98
26 Q13.21
25 Q43.79
25 Q34.23
25 Q24.89
25 Q15.46
24 Q46.15
24 Q36.76
24 Q27.26
24 Q17.57
Expenses (USD) · TTM
0100M200M300MR&DSG&ACapex24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
ACLS Expenses (USD) · TTM by quarter
PeriodExpenses (USD) · TTM
26 Q2292.83M
26 Q1278.73M
25 Q4268.83M
25 Q3257.08M
25 Q2258.24M
25 Q1259.48M
24 Q4256.04M
24 Q3258.69M
24 Q2255.04M
24 Q1252.39M
Shares Outstanding (USD) · TTM
-50M050M100M150MBuybacks (Repurchases)Stock-Based Compensation24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
ACLS Shares Outstanding (USD) · TTM by quarter
PeriodShares Outstanding (USD) · TTM
26 Q236.04M
26 Q182.13M
25 Q4100.31M
25 Q389.93M
25 Q272.89M
25 Q142.5M
24 Q439.54M
24 Q339.55M
24 Q237.02M
24 Q135.24M
Employee Count
05001K1.5K2K2016201720182019202020212022202320242025
ACLS Employee Count by quarter
PeriodEmployee Count
20251.47K
20241.52K
20231.62K
20221.39K
20211.12K
20201K
2019960
2018992
2017896
2016814
PE Ratio
0204060med 16.8Dec 24Apr 25Jul 25Oct 25Feb 26May 26Sep 26
ACLS PE Ratio by quarter
PeriodPE Ratio
Sep 2637.66
Sep 2638.21
Aug 2638.37
Aug 2642.19
Aug 2646.53
Aug 2646.57
Jul 2639.71
Jul 2640.84
Jul 2641.55
Jul 2643.66
Jul 2644.01
Jun 2652.76
Jun 2657.12
Jun 2654.86
Jun 2644.82
May 2645.81
May 2647.8
May 2647.26
May 2649.65
May 2636.01
Apr 2636.81
Apr 2630.54
Apr 2628.39
Apr 2624.46
Mar 2625.04
Mar 2621.72
Mar 2621.4
Mar 2621.15
Feb 2621.25
Feb 2618.47
Feb 2621.78
Feb 2619.83
Jan 2620.29
Jan 2620.99
Jan 2621.45
Jan 2621.45
Jan 2619.84
Dec 2519.03
Dec 2519.06
Dec 2519.72
Dec 2520.92
Nov 2519.07
Nov 2517.71
Nov 2518.79
Nov 2519.75
Oct 2516.09
Oct 2516.85
Oct 2516.76
Oct 2516.01
Oct 2517.94
Sep 2519.71
Sep 2519.34
Sep 2517.3
Sep 2516.3
Aug 2516.19
Aug 2516.44
Aug 2516.28
Aug 2516.06
Aug 2512.46
Jul 2513.3
Jul 2512.86
Jul 2513.57
Jul 2513.24
Jun 2512.63
Jun 2511.97
Jun 2511.79
Jun 2511.51
May 2510.21
May 2510.57
May 2511.16
May 2510.45
May 258.44
Apr 258.04
Apr 257.22
Apr 257.59
Apr 256.84
Mar 258.02
Mar 259.02
Mar 259.43
Mar 259.78
Feb 258.84
Feb 259.25
Feb 258.95
Feb 259.36
Jan 259.97
Jan 2510.38
Jan 2510.5
Jan 2510.18
Jan 2510.55
Dec 2410.44
Dec 2410.18
Dec 2411.03
Dec 2410.87
Nov 2410.88
Nov 2411
Nov 2410.73
Nov 2412.47
Nov 2411.72
Oct 2412.24
Oct 2412.56
Free Cash Flow Yield
0%2%4%6%8%10%med 4.79%Dec 24Apr 25Jul 25Oct 25Feb 26May 26Sep 26
ACLS Free Cash Flow Yield by quarter
PeriodFree Cash Flow Yield
Sep 261.88%
Sep 261.85%
Aug 261.84%
Aug 261.67%
Aug 261.52%
Aug 261.52%
Jul 262.21%
Jul 262.15%
Jul 262.11%
Jul 262.01%
Jul 261.99%
Jun 261.66%
Jun 261.54%
Jun 261.6%
Jun 261.96%
May 261.91%
May 261.83%
May 261.86%
May 261.77%
May 262.47%
Apr 262.42%
Apr 262.91%
Apr 263.14%
Apr 263.64%
Mar 263.55%
Mar 264.1%
Mar 264.16%
Mar 264.21%
Feb 264.19%
Feb 264.94%
Feb 264.19%
Feb 264.6%
Jan 264.5%
Jan 264.35%
Jan 264.25%
Jan 264.26%
Jan 264.6%
Dec 254.8%
Dec 254.79%
Dec 254.63%
Dec 254.36%
Nov 254.79%
Nov 255.15%
Nov 254.86%
Nov 254.62%
Oct 254.81%
Oct 254.59%
Oct 254.61%
Oct 254.83%
Oct 254.31%
Sep 253.92%
Sep 254%
Sep 254.47%
Sep 254.74%
Aug 254.78%
Aug 254.7%
Aug 254.75%
Aug 254.81%
Aug 255.54%
Jul 255.19%
Jul 255.37%
Jul 255.09%
Jul 255.21%
Jun 255.47%
Jun 255.77%
Jun 255.85%
Jun 256%
May 256.76%
May 256.53%
May 256.19%
May 256.61%
May 257.59%
Apr 257.96%
Apr 258.86%
Apr 258.43%
Apr 259.35%
Mar 257.98%
Mar 257.1%
Mar 256.79%
Mar 256.54%
Feb 257.24%
Feb 258.56%
Feb 258.85%
Feb 258.46%
Jan 257.95%
Jan 257.63%
Jan 257.55%
Jan 257.78%
Jan 257.51%
Dec 247.59%
Dec 247.78%
Dec 247.18%
Dec 247.29%
Nov 247.28%
Nov 247.2%
Nov 247.38%
Nov 246.35%
Nov 245.45%
Oct 245.21%
Oct 245.08%
Price to Sales
02468med 2.92Dec 24Apr 25Jul 25Oct 25Feb 26May 26Sep 26
ACLS Price to Sales by quarter
PeriodPrice to Sales
Sep 264.03
Sep 264.09
Aug 264.11
Aug 264.52
Aug 264.98
Aug 264.99
Jul 264.74
Jul 264.87
Jul 264.96
Jul 265.21
Jul 265.25
Jun 266.3
Jun 266.81
Jun 266.55
Jun 265.35
May 265.47
May 265.7
May 265.64
May 265.92
May 265.16
Apr 265.28
Apr 264.38
Apr 264.07
Apr 263.5
Mar 263.59
Mar 263.11
Mar 263.07
Mar 263.03
Feb 263.04
Feb 262.94
Feb 263.47
Feb 263.16
Jan 263.23
Jan 263.34
Jan 263.42
Jan 263.42
Jan 263.16
Dec 253.03
Dec 253.04
Dec 253.14
Dec 253.33
Nov 253.04
Nov 252.82
Nov 252.99
Nov 253.15
Oct 252.85
Oct 252.98
Oct 252.96
Oct 252.83
Oct 253.17
Sep 253.49
Sep 253.42
Sep 253.06
Sep 252.88
Aug 252.86
Aug 252.91
Aug 252.88
Aug 252.84
Aug 252.31
Jul 252.47
Jul 252.39
Jul 252.52
Jul 252.46
Jun 252.35
Jun 252.22
Jun 252.19
Jun 252.14
May 251.9
May 251.96
May 252.07
May 251.94
May 251.67
Apr 251.59
Apr 251.43
Apr 251.5
Apr 251.35
Mar 251.58
Mar 251.78
Mar 251.86
Mar 251.93
Feb 251.75
Feb 251.91
Feb 251.85
Feb 251.93
Jan 252.06
Jan 252.14
Jan 252.17
Jan 252.1
Jan 252.18
Dec 242.16
Dec 242.1
Dec 242.28
Dec 242.24
Nov 242.25
Nov 242.27
Nov 242.22
Nov 242.57
Nov 242.52
Oct 242.64
Oct 242.71
EV/EBITDA
010203040med 10.54Dec 24Apr 25Jul 25Oct 25Feb 26May 26Sep 26
ACLS EV/EBITDA by quarter
PeriodEV/EBITDA
Sep 2624.54
Sep 2624.94
Aug 2625.06
Aug 2627.83
Aug 2630.99
Aug 2631.01
Jul 2626.77
Jul 2627.6
Jul 2628.12
Jul 2629.67
Jul 2629.92
Jun 2636.34
Jun 2639.54
Jun 2637.88
Jun 2630.52
May 2631.24
May 2632.7
May 2632.31
May 2634.06
May 2625
Apr 2625.6
Apr 2620.88
Apr 2619.27
Apr 2616.31
Mar 2616.75
Mar 2614.25
Mar 2614.01
Mar 2613.83
Feb 2613.9
Feb 2611.78
Feb 2614.31
Feb 2612.82
Jan 2613.17
Jan 2613.71
Jan 2614.06
Jan 2614.05
Jan 2612.83
Dec 2512.21
Dec 2512.23
Dec 2512.74
Dec 2513.65
Nov 2512.24
Nov 2511.21
Nov 2512.03
Nov 2512.76
Oct 259.99
Oct 2510.57
Oct 2510.51
Oct 259.93
Oct 2511.42
Sep 2512.79
Sep 2512.51
Sep 2510.93
Sep 2510.15
Aug 2510.06
Aug 2510.26
Aug 2510.14
Aug 259.96
Aug 257.4
Jul 258.06
Jul 257.72
Jul 258.27
Jul 258.01
Jun 257.54
Jun 257.01
Jun 256.88
Jun 256.65
May 255.63
May 255.91
May 256.38
May 255.82
May 254.64
Apr 254.33
Apr 253.67
Apr 253.97
Apr 253.37
Mar 254.31
Mar 255.11
Mar 255.44
Mar 255.72
Feb 254.96
Feb 255.43
Feb 255.2
Feb 255.52
Jan 256
Jan 256.33
Jan 256.42
Jan 256.17
Jan 256.47
Dec 246.38
Dec 246.18
Dec 246.85
Dec 246.72
Nov 246.73
Nov 246.83
Nov 246.61
Nov 247.99
Nov 247.75
Oct 248.17
Oct 248.43
Price/Operating Cashflow
0204060med 18.7Dec 24Apr 25Jul 25Oct 25Feb 26May 26Sep 26
ACLS Price/Operating Cashflow by quarter
PeriodPrice/Operating Cashflow
Sep 2646.41
Sep 2647.08
Aug 2647.28
Aug 2651.99
Aug 2657.34
Aug 2657.39
Jul 2641.45
Jul 2642.63
Jul 2643.37
Jul 2645.57
Jul 2645.93
Jun 2655.07
Jun 2659.61
Jun 2657.26
Jun 2646.78
May 2647.81
May 2649.89
May 2649.33
May 2651.82
May 2636.59
Apr 2637.41
Apr 2631.04
Apr 2628.85
Apr 2624.86
Mar 2625.45
Mar 2622.07
Mar 2621.75
Mar 2621.5
Feb 2621.59
Feb 2618.23
Feb 2621.51
Feb 2619.58
Jan 2620.03
Jan 2620.72
Jan 2621.18
Jan 2621.18
Jan 2619.59
Dec 2518.79
Dec 2518.81
Dec 2519.47
Dec 2520.66
Nov 2518.83
Nov 2517.49
Nov 2518.55
Nov 2519.5
Oct 2518.47
Oct 2519.34
Oct 2519.24
Oct 2518.39
Oct 2520.6
Sep 2522.63
Sep 2522.21
Sep 2519.86
Sep 2518.72
Aug 2518.58
Aug 2518.87
Aug 2518.69
Aug 2518.44
Aug 2516.03
Jul 2517.11
Jul 2516.54
Jul 2517.45
Jul 2517.03
Jun 2516.24
Jun 2515.39
Jun 2515.17
Jun 2514.8
May 2513.13
May 2513.59
May 2514.35
May 2513.44
May 2512.04
Apr 2511.48
Apr 2510.31
Apr 2510.83
Apr 259.77
Mar 2511.45
Mar 2512.87
Mar 2513.46
Mar 2513.96
Feb 2512.62
Feb 2510.61
Feb 2510.27
Feb 2510.74
Jan 2511.43
Jan 2511.91
Jan 2512.04
Jan 2511.67
Jan 2512.1
Dec 2411.98
Dec 2411.68
Dec 2412.66
Dec 2412.47
Nov 2412.48
Nov 2412.62
Nov 2412.31
Nov 2414.3
Nov 2416.33
Oct 2417.05
Oct 2417.5
Price to Book
0246med 2.53Dec 24Apr 25Jul 25Oct 25Feb 26May 26Sep 26
ACLS Price to Book by quarter
PeriodPrice to Book
Sep 263.28
Sep 263.33
Aug 263.34
Aug 263.67
Aug 264.05
Aug 264.05
Jul 263.83
Jul 263.94
Jul 264.01
Jul 264.22
Jul 264.25
Jun 265.09
Jun 265.52
Jun 265.3
Jun 264.33
May 264.42
May 264.62
May 264.56
May 264.79
May 264.18
Apr 264.28
Apr 263.55
Apr 263.3
Apr 262.84
Mar 262.91
Mar 262.52
Mar 262.49
Mar 262.46
Feb 262.47
Feb 262.46
Feb 262.9
Feb 262.64
Jan 262.7
Jan 262.8
Jan 262.86
Jan 262.86
Jan 262.64
Dec 252.54
Dec 252.54
Dec 252.63
Dec 252.79
Nov 252.54
Nov 252.36
Nov 252.5
Nov 252.63
Oct 252.49
Oct 252.61
Oct 252.6
Oct 252.48
Oct 252.78
Sep 253.06
Sep 253
Sep 252.68
Sep 252.53
Aug 252.51
Aug 252.55
Aug 252.52
Aug 252.49
Aug 252.16
Jul 252.3
Jul 252.23
Jul 252.35
Jul 252.29
Jun 252.19
Jun 252.07
Jun 252.04
Jun 251.99
May 251.77
May 251.83
May 251.93
May 251.81
May 251.67
Apr 251.6
Apr 251.43
Apr 251.51
Apr 251.36
Mar 251.59
Mar 251.79
Mar 251.87
Mar 251.94
Feb 251.75
Feb 252.11
Feb 252.04
Feb 252.13
Jan 252.27
Jan 252.36
Jan 252.39
Jan 252.32
Jan 252.4
Dec 242.38
Dec 242.32
Dec 242.51
Dec 242.48
Nov 242.48
Nov 242.5
Nov 242.44
Nov 242.84
Nov 243
Oct 243.13
Oct 243.22
Axcelis Technologies, Inc.
ACLS
Stockpicker

Video analysis: ACLS

All videos

No video analysis for this stock yet. Request one from our team.

Your email is used only to follow up on this request. We do not add you to marketing lists. Privacy Policy

News: ACLS

Axcelis Technologies Inc (ACLS) Shares Fall 3.0% -- GF Value Says Still Overvalued

gurufocus.com · 9 Sep 2026

Axcelis Technologies Inc (ACLS) Shares Fall 3.0% -- GF Value Says Still Overvalued

On September 09, 2026, Axcelis Technologies Inc (ACLS) shares fell 3.0%, closing at $115.56. The stock has experienced volatility over the past year, with a 52-

Axcelis Technologies (ACLS) Declines More Than Market: Some Information for Investors

zacks.com · 9 Sep 2026

Axcelis Technologies (ACLS) Declines More Than Market: Some Information for Investors

Axcelis Technologies (ACLS) closed the most recent trading day at $115.56, moving 3.03% from the previous trading session.

Axcelis to Build New Manufacturing Facility in Pyeongtaek, Korea

prnewswire.com · 8 Sep 2026

Axcelis to Build New Manufacturing Facility in Pyeongtaek, Korea

BEVERLY, Mass., Sept. 8, 2026 /PRNewswire/ -- Axcelis Technologies, Inc. (Nasdaq: ACLS), a leading supplier of enabling ion implantation solutions for the semiconductor industry, today announced plans to invest $35 million in its global manufacturing infrastructure through the construction of a new ion implantation equipment manufacturing facility in Pyeongtaek, Gyeonggi Province, Korea.

Axcelis Announces Participation in Upcoming Investor Conferences

prnewswire.com · 1 Sep 2026

Axcelis Announces Participation in Upcoming Investor Conferences

BEVERLY, Mass., Sept. 1, 2026 /PRNewswire/ -- Axcelis Technologies, Inc. (NASDAQ: ACLS), a leading supplier of enabling ion implantation solutions for the semiconductor industry, announced the company's plans to participate in the following upcoming investor conferences: The Citi 2026 Global TMT Conference on Tuesday, September 8th at the New York Hilton Midtown.

Is the Options Market Predicting a Spike in Axcelis Technologies Stock?

zacks.com · 25 Aug 2026

Is the Options Market Predicting a Spike in Axcelis Technologies Stock?

Investors need to pay close attention to ACLS stock based on the movements in the options market lately.

Is Axcelis Stock a Buy?

fool.com · 21 Aug 2026

Is Axcelis Stock a Buy?

Business is accelerating at the perfect moment.

Cetera Investment Advisers Sells 4,828 Shares of Axcelis Technologies, Inc. $ACLS

defenseworld.net · 20 Aug 2026

Cetera Investment Advisers Sells 4,828 Shares of Axcelis Technologies, Inc. $ACLS

Cetera Investment Advisers trimmed its position in Axcelis Technologies, Inc. (NASDAQ: ACLS) by 48.5% during the first quarter, according to its most recent 13F filing with the SEC. The fund owned 5,127 shares of the semiconductor company's stock after selling 4,828 shares during the period. Cetera Investment Advisers' holdings in Axcelis Technologies were

Axcelis Technologies Inc (ACLS) Shares Fall 5.9% -- What GF Score of 91 Tells Investors

gurufocus.com · 18 Aug 2026

Axcelis Technologies Inc (ACLS) Shares Fall 5.9% -- What GF Score of 91 Tells Investors

On August 18, 2026, Axcelis Technologies Inc (ACLS) shares fell 5.9%, bringing the current price to $135.36. Over the past year, the stock has seen a high of $1

Similar companies

Disclaimer: The historical data presented on this platform is provided by Financial Modeling Prep. Stock Picker is a platform for informational purposes only and does not provide financial advice. Users are encouraged to conduct their own research and consult with a qualified financial advisor before making investment decisions.